531 related articles for article (PubMed ID: 12673891)
21. Soluble interleukin-2 receptor in sera and synovial fluids of rheumatoid patients: correlations with disease activity.
Carotti M; Salaffi F; Ferraccioli GF; Binci MC; Sartini A; Cervini C
Rheumatol Int; 1994; 14(2):47-52. PubMed ID: 7824835
[TBL] [Abstract][Full Text] [Related]
22. Serum concentrations of soluble interleukin 2 receptor in patients with rheumatoid arthritis: effect of second line drugs.
Crilly A; Madhok R; Watson J; Capell HA
Ann Rheum Dis; 1993 Jan; 52(1):58-60. PubMed ID: 8093995
[TBL] [Abstract][Full Text] [Related]
23. Similar serum levels of IL-6 and its soluble receptors in patients with HCV-related arthritis and rheumatoid arthritis: a pilot study.
Riccio A; Postiglione L; Sabatini P; Linvelli M; Soriente I; Sangiolo MG; Amato P; Tarantino G
Int J Immunopathol Pharmacol; 2012; 25(1):281-5. PubMed ID: 22507342
[TBL] [Abstract][Full Text] [Related]
24. The advanced glycation end product pentosidine correlates to IL-6 and other relevant inflammatory markers in rheumatoid arthritis.
Hein GE; Köhler M; Oelzner P; Stein G; Franke S
Rheumatol Int; 2005 Dec; 26(2):137-41. PubMed ID: 15580352
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-2 receptor levels in sera of patients with rheumatoid arthritis treated with sulfasalazine, parenteral gold, or placebo.
Merkel PA; Dooley MA; Dawson DV; Pisetsky DS; Polisson RP
J Rheumatol; 1996 Nov; 23(11):1856-61. PubMed ID: 8923356
[TBL] [Abstract][Full Text] [Related]
26. [The significance of soluble IL-2 receptors in rheumatoid arthritis with interstitial pneumonia].
Tada S; Namba J; Yokota S; Sugimoto K; Imajo K; Kawabata H; Irie S; Kimura I; Kitani H; Tanizaki K
Arerugi; 1992 Mar; 41(3):428-33. PubMed ID: 1575640
[TBL] [Abstract][Full Text] [Related]
27. [Study on relationship between two different syndromes and three soluble cytokine receptors in patients with rheumatoid arthritis].
Hu Z; Hong J; Gao M
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1999 Dec; 19(12):718-20. PubMed ID: 11783141
[TBL] [Abstract][Full Text] [Related]
28. Soluble interleukin-2 receptor: elevated levels in serum and synovial fluid of patients with rheumatoid arthritis.
Carpenter AB; Eisenbeis CH; Carrabis S; Brown MC; Ip SH
J Clin Lab Anal; 1990; 4(2):130-4. PubMed ID: 2313471
[TBL] [Abstract][Full Text] [Related]
29. Concentrations and origins of soluble interleukin 6 receptor-alpha in serum and synovial fluid.
Desgeorges A; Gabay C; Silacci P; Novick D; Roux-Lombard P; Grau G; Dayer JM; Vischer T; Guerne PA
J Rheumatol; 1997 Aug; 24(8):1510-6. PubMed ID: 9263143
[TBL] [Abstract][Full Text] [Related]
30. Impaired urinary excretion of soluble IL-2 receptors in patients with systemic lupus erythematosus and rheumatoid arthritis.
Manoussakis MN; Germanidis GS; Drosos AA; Moutsopoulos HM
Lupus; 1992 Feb; 1(2):105-9. PubMed ID: 1301961
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease.
Nishimoto N; Terao K; Mima T; Nakahara H; Takagi N; Kakehi T
Blood; 2008 Nov; 112(10):3959-64. PubMed ID: 18784373
[TBL] [Abstract][Full Text] [Related]
32. Soluble IL-2 receptor in rheumatoid arthritis. Correlation with disease activity, IL-1 and IL-2 inhibition.
Symons JA; Wood NC; Di Giovine FS; Duff GW
J Immunol; 1988 Oct; 141(8):2612-8. PubMed ID: 3262665
[TBL] [Abstract][Full Text] [Related]
33. The effects of nonsteroidal antiinflammatory drug therapy in early rheumatoid arthritis on serum levels of soluble interleukin 2 receptor, CD4, and CD8.
Dooley MA; Cush JJ; Lipsky PE; Dawson DV; Pisetsky DS
J Rheumatol; 1993 Nov; 20(11):1857-62. PubMed ID: 8308770
[TBL] [Abstract][Full Text] [Related]
34. Influence of corticosteroid pulse therapy on the serum levels of soluble interleukin 2 receptor, interleukin 6 and interleukin 8 in patients with rheumatoid arthritis.
van den Brink HR; van Wijk MJ; Geertzen RG; Bijlsma JW
J Rheumatol; 1994 Mar; 21(3):430-4. PubMed ID: 7911833
[TBL] [Abstract][Full Text] [Related]
35. Serum soluble interleukin 2 receptor levels and radiological progression in early rheumatoid arthritis.
Camilleri JP; Amos N; Williams BD; Emery P; Williams LA; Jessop JD
J Rheumatol; 2001 Dec; 28(12):2576-8. PubMed ID: 11764199
[TBL] [Abstract][Full Text] [Related]
36. [The serum level of soluble interleukin-2 receptors in patients with rheumatoid arthritis].
Medvedev AN; Korshunov NI; Nasonov EL; Baranov AA; Shilkina NP
Ter Arkh; 1996; 68(5):24-7. PubMed ID: 9082592
[TBL] [Abstract][Full Text] [Related]
37. Tissue cytokine patterns distinguish variants of rheumatoid synovitis.
Klimiuk PA; Goronzy JJ; Björ nsson J; Beckenbaugh RD; Weyand CM
Am J Pathol; 1997 Nov; 151(5):1311-9. PubMed ID: 9358757
[TBL] [Abstract][Full Text] [Related]
38. [Value of serum soluble interleukin-2R, interleukin-6 and C-reactive protein in the early diagnosis of Kawasaki disease].
Peng Q; Wu Q; Chen CH; Hong H; Zhang LY
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Jun; 8(3):208-10. PubMed ID: 16787593
[TBL] [Abstract][Full Text] [Related]
39. [Serum soluble interleukin 2 receptor levels in patients with diffuse connective tissue diseases].
Sun HY; Liu WL; Xiu HZ
Zhonghua Nei Ke Za Zhi; 1993 Aug; 32(8):528-30. PubMed ID: 8269781
[TBL] [Abstract][Full Text] [Related]
40. [A study of cytokine expression in peripheral blood of patients with Graves' ophthalmopathy].
Tang L; Luo Q; Zhou X; Xia R
Zhonghua Yan Ke Za Zhi; 2002 Mar; 38(3):165-7. PubMed ID: 11955323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
